Literature DB >> 11044366

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.

P Baumann1, P Zigrino, C Mauch, D Breitkreutz, R Nischt.   

Abstract

Elevated expression of type IV collagenases (MMP-2 and MMP-9) has been strongly correlated with tumour progression and metastasis in various tumours. Here, we analysed expression and activation of these MMPs in non-tumourigenic HaCaT cells and the malignant HaCaT variant II-4(rt). In monolayer cultures, both cell types secreted latent MMP-2 (proMMP-2) in comparable amounts, while MMP-9 production was clearly higher in II-4(rt)cells. Upon contact with fibrillar collagen type I the malignant II-4(rt)cells, but not the HaCaT cells, gained the capability to activate proMMP-2. This process is shown to be membrane-associated and mediated by MT1-MMP. Surprisingly, all membrane preparations from either HaCaT cells or II-4(rt)cells grown as monolayers, as well as within collagen gels, contained considerable amounts of active MT1-MMP. However, within collagen gels HaCaT cells showed significantly higher TIMP-2 levels compared to II-4(rt)cells. This indicates that TIMP-2 might play a central role for MT1-MMP-mediated gelatinolytic activity. Indeed, collagen type I-induced MT1-MMP-mediated proMMP-2 activation by II-4(rt)membranes could be completely abolished by an excess of TIMP-2. In conclusion, our data suggest that MT1-MMP-mediated proMMP-2 activation might be associated with malignant progression of epidermal tumour cells. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044366      PMCID: PMC2408778          DOI: 10.1054/bjoc.2000.1454

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).

Authors:  H Sato; T Takino; T Kinoshita; K Imai; Y Okada; W G Stetler Stevenson; M Seiki
Journal:  FEBS Lett       Date:  1996-05-06       Impact factor: 4.124

2.  Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator.

Authors:  Y Okumura; H Sato; M Seiki; H Kido
Journal:  FEBS Lett       Date:  1997-02-03       Impact factor: 4.124

3.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

4.  Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain.

Authors:  J Cao; A Rehemtulla; W Bahou; S Zucker
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

5.  Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.

Authors:  D Pei; S J Weiss
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

6.  Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.

Authors:  C Gilles; M Polette; M Seiki; P Birembaut; E W Thompson
Journal:  Lab Invest       Date:  1997-05       Impact factor: 5.662

Review 7.  Molecular regulation of cellular invasion--role of gelatinase A and TIMP-2.

Authors:  A E Yu; R E Hewitt; D E Kleiner; W G Stetler-Stevenson
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

8.  Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay.

Authors:  Y Tsunezuka; H Kinoh; T Takino; Y Watanabe; Y Okada; A Shinagawa; H Sato; M Seiki
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

9.  The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

Authors:  H Will; S J Atkinson; G S Butler; B Smith; G Murphy
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

10.  Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.

Authors:  G S Butler; H Will; S J Atkinson; G Murphy
Journal:  Eur J Biochem       Date:  1997-03-01
View more
  4 in total

1.  Matrix metalloproteinase (MMP) and TGF beta 1-stimulated cell migration in skin and cornea wound healing.

Authors:  Choun-Ki Joo; Young Seomun
Journal:  Cell Adh Migr       Date:  2008-10-11       Impact factor: 3.405

2.  Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines.

Authors:  D Nova; C Le Griel; S Holvoet; E Gentilhomme; C Vincent; M J Staquet; D Schmitt; M Serres
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Lumican - derived peptides inhibit melanoma cell growth and migration.

Authors:  Katarzyna Pietraszek; Stéphane Brézillon; Corinne Perreau; Maria Malicka-Błaszkiewicz; François-Xavier Maquart; Yanusz Wegrowski
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

4.  Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.

Authors:  Marta Stasiak; Joanna Boncela; Corinne Perreau; Konstantina Karamanou; Aurore Chatron-Colliet; Isabelle Proult; Patrycja Przygodzka; Shukti Chakravarti; François-Xavier Maquart; M Anna Kowalska; Yanusz Wegrowski; Stéphane Brézillon
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.